Posted inBiotechnology
Posted inGenetics
Akamis Bio Raises $60 Million for Cancer Gene Therapy, Signs Licensing Deal with Xuanzhu Biopharma
Akamis Bio, a clinical-stage oncology company, has raised $60 million in Series A funding that will drive continued development of…























